Clinical trials
Phase 1/2 Carcinoma, Hepatocellular trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| AstraZeneca | 2 |
| Eisai Inc. | 2 |
| BeOne Medicines | 1 |
| Daiichi Sankyo | 1 |
| Eisai Co., Ltd. | 1 |
| Kindai University | 1 |
| Novartis Pharmaceuticals | 1 |
| Otsuka Pharmaceutical Co., Ltd. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 16 |
| Liver Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Melanoma | 2 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Transitional Cell | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.